Oncology Deals Dashboard

Enter your 6-digit access code

Oncology Dealmaking: Phase 1 & 2, US Market (2023-2025)

M&A | Licensing & Co-Development | Collaborations | Equity/Financing | Asset Acquisitions

Overview
All Deals
By Year
By Deal Type
By Modality
Top Buyers
China Licensing
Valuation
2026 Forecast